Three key takeaways to consider before building a biorefinery

Macroeconomic headwinds have forced the bio-based industry to evolve as emerging technologies realign to the latest market realities (see the report "Alternative Fuels Year in Review"). With low oil prices, many alternative fuels companies desperately pivoted business models for higher-value mark...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email Thank you!

Related Research

LanzaTech sets its eyes on consumer packaged goods for its CO₂-derived ethanol and chemicals

Analyst Insight | February 11, 2022

It is no longer a hypothetical nor a pipe dream — LanzaTech's CO2‑derived chemicals have begun to make their way onto the market in consumer products, with new fragrance products slated to reach stores in the next few months. The fragrances are produced by multinational beauty company Coty and ... Not part of subscription

Getting innovation timing right: SPAC deal sets LanzaTech up for growth and success

Case Study | March 24, 2022

LanzaTech initially began as a company seeking to commercialize its microbial gas‑to‑alcohol technology. Despite the skepticism and challenges that come with synthetic biology conversion, the company has made considerable commercial strides and established itself in multiple downstream CO2 ... Not part of subscription


Company Profile | April 04, 2022

Virent is a wholly owned subsidiary of Marathon Petroleum Corporation Converts biobased feedstocks into fuels and aromatic chemicals via an aqueous‑phase catalytic process; products are drop‑in replacements for petroleum‑based fuels and chemicals Claims to be able to use the same catalytic ... Not part of subscription